Related references
Note: Only part of the references are listed.A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice
L. I. Plotkin et al.
BONE (2011)
The relationship between the chemistry and biological activity of the bisphosphonates
Frank H. Ebetino et al.
BONE (2011)
Differences Between Bisphosphonates in Binding Affinities for Hydroxyapatite
M. A. Lawson et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2010)
Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: The effect of a bisphosphonate
Clemens W.G.M. Löwik et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Fluorescent Risedronate Analogues Reveal Bisphosphonate Uptake by Bone Marrow Monocytes and Localization Around Osteocytes In Vivo
Anke J. Roelofs et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Thermodynamics of Bisphosphonates Binding to Human Bone: A Two-Site Model
Sujoy Mukherjee et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Fluorescently Labeled Risedronate and Related Analogues: Magic Linker Synthesis
Boris A. Kashemirov et al.
BIOCONJUGATE CHEMISTRY (2008)
Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells
Fraser P. Coxon et al.
BONE (2008)
Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro
Zachary J. Henneman et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2008)
Connexin 43 Is Required for the Anti-Apoptotic Effect of Bisphosphonates on Osteocytes and Osteoblasts In Vivo
Lilian I. Plotkin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model
Sujoy Mukherjee et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
R. G. G. Russell et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Synthesis and biological evaluation of α-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate
Mong S. Marma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Noninvasive optical detection of bone mineral
Kenneth M. Kozloff et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading
Helene Follet et al.
BONE (2007)
Retention, distribution, and effects of intraosseously administered ibandronate in the infarcted femoral head
James Aya-ay et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs
Lilian I. Plotkin et al.
BONE (2006)
The molecular mechanism of nitrogen-containing bisphosphonates as anti osteoporosis drugs
Kathryn L. Kavanagh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite
G. H. Nancollas et al.
BONE (2006)
Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy
Chih-Tai Leu et al.
BONE (2006)
Transduction of cell survival signals by connexin-43 hemichannels
LI Plotkin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: The role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors
ER Van Beek et al.
BONE (2002)
Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages
FP Coxon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
